Wim Timens Selected Research

Wim Timens Research Topics

Disease

106	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 10/2003
35	Asthma (Bronchial Asthma) 11/2023 - 06/2005
34	Inflammation (Inflammations) 07/2022 - 08/2002
22	Neoplasms (Cancer) 04/2024 - 11/2002
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 11/2002
16	Emphysema 01/2021 - 07/2003
12	Lung Neoplasms (Lung Cancer) 11/2020 - 05/2006
11	Lung Diseases (Lung Disease) 04/2024 - 08/2004
6	Airway Remodeling 01/2022 - 01/2013
5	Fibrosis (Cirrhosis) 04/2024 - 07/2006
4	Adenocarcinoma of Lung 11/2021 - 12/2010
4	COVID-19 06/2021 - 01/2020
4	Respiratory Hypersensitivity 01/2021 - 06/2004
3	Disease Progression 03/2024 - 01/2008
3	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2023 - 11/2012
3	Adenocarcinoma 02/2022 - 01/2011
3	Pneumonia (Pneumonitis) 01/2016 - 01/2008
3	Airway Obstruction (Choking) 10/2015 - 07/2006
2	Idiopathic Pulmonary Fibrosis 02/2024 - 05/2023
2	Systemic Scleroderma (Systemic Sclerosis) 11/2023 - 01/2023
2	Pulmonary Arterial Hypertension 01/2023 - 11/2020
2	Chronic Bronchitis 01/2020 - 11/2005
2	Vascular Remodeling 01/2016 - 03/2015
2	Chronic Disease (Chronic Diseases) 01/2013 - 01/2011

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2002
29	SmokeIBA 01/2022 - 07/2003
23	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2007
14	CytokinesIBA 11/2023 - 08/2002
13	Biomarkers (Surrogate Marker)IBA 04/2024 - 05/2013
12	Messenger RNA (mRNA)IBA 01/2021 - 03/2004
10	CollagenIBA 11/2023 - 01/2009
10	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
9	SteroidsIBA 01/2023 - 10/2009
8	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2020
8	DecorinIBA 01/2021 - 03/2005
7	GoldIBA 01/2020 - 12/2008
7	Fluticasone (Cutivate)FDA LinkGeneric 01/2019 - 10/2009
7	multidrug resistance-associated protein 1IBA 12/2012 - 06/2005
6	LigandsIBA 11/2023 - 08/2003
5	InterleukinsIBA 01/2020 - 07/2005
4	Anaplastic Lymphoma KinaseIBA 01/2023 - 12/2010
4	B7-H1 AntigenIBA 01/2022 - 10/2019
4	Bronchodilator Agents (Bronchodilators)IBA 01/2021 - 03/2011
4	OvalbuminIBA 01/2016 - 08/2002
4	Interleukin-8 (Interleukin 8)IBA 01/2016 - 04/2005
4	Adenosine Monophosphate (AMP)IBA 01/2015 - 06/2008
3	Peptides (Polypeptides)IBA 04/2024 - 09/2013
3	ChemokinesIBA 11/2023 - 07/2007
3	Immune Checkpoint InhibitorsIBA 12/2022 - 11/2021
3	AntibodiesIBA 11/2022 - 04/2006
3	Formaldehyde (Formol)FDA Link 11/2022 - 10/2020
3	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2017
3	ElastinIBA 02/2022 - 11/2009
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2005
3	Angiotensin-Converting Enzyme 2IBA 12/2020 - 01/2020
3	Transforming Growth Factor beta (TGF-beta)IBA 11/2020 - 12/2008
3	GasesIBA 01/2020 - 01/2009
3	Proteoglycans (Proteoglycan)IBA 01/2018 - 12/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 07/2006
3	AntigensIBA 08/2012 - 04/2006
2	Interleukin-33IBA 11/2023 - 01/2016
2	GlucocorticoidsIBA 01/2023 - 11/2015
2	Vasodilator Agents (Vasodilators)IBA 01/2023 - 01/2021
2	Receptor for Advanced Glycation End ProductsIBA 01/2023 - 01/2021
2	ParaffinIBA 11/2022 - 10/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2022 - 06/2011
2	Tyrosine Kinase InhibitorsIBA 10/2022 - 12/2019
2	Circulating Tumor DNAIBA 11/2021 - 11/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 12/2011
2	ParaquatIBA 01/2021 - 01/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2021 - 01/2020
2	Serine Proteases (Serine Protease)IBA 12/2020 - 11/2020
2	Budesonide (Pulmicort)FDA LinkGeneric 10/2020 - 01/2013
2	Interleukin-1 (Interleukin 1)IBA 01/2020 - 01/2017
2	Phosphodiesterase 4 InhibitorsIBA 01/2020 - 10/2003
2	AllergensIBA 12/2019 - 07/2006
2	Laminin (Merosin)IBA 12/2019 - 01/2009
2	Chemokine ReceptorsIBA 03/2019 - 03/2004
2	ErbB Receptors (EGF Receptor)IBA 03/2019 - 12/2010
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 07/2005
2	CrizotinibIBA 01/2018 - 01/2016
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2017 - 11/2012
2	Phosphotransferases (Kinase)IBA 11/2015 - 06/2011
2	Nicotine FDA Link 10/2015 - 01/2012
2	CateninsIBA 01/2015 - 01/2011
2	erythromycin propionate-N-acetylcysteinateIBA 11/2014 - 01/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2013 - 12/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013 - 12/2009
2	AutoantibodiesIBA 08/2012 - 12/2010
2	Interleukin-13IBA 12/2011 - 06/2008
2	Fibronectins (Fibronectin)IBA 01/2011 - 03/2005
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2009 - 06/2008
2	Adenosine (Adenocard)FDA LinkGeneric 03/2009 - 06/2008
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2009 - 03/2004

Therapy/Procedure

33	Therapeutics 04/2024 - 10/2003
9	Immunotherapy 04/2024 - 05/2016
3	Drug Therapy (Chemotherapy) 10/2022 - 04/2015
3	Lung Transplantation 04/2009 - 08/2004
2	Lasers (Laser) 12/2023 - 05/2011